Search results for "Integument"

showing 10 items of 754 documents

A retrospective study of 370 patients with oral lichen planus in Turkey.

2012

Objectives: Although several detailed studies concerning the patient profile and clinical features of oral lichen planus have been undertaken all over the world in different populations, a similar study has not yet been conducted in a Turkish population. The purpose of this retrospective study was to describe the demographic and clinical characteristics of a group of patients with oral lichen planus in Turkey. Study Design: Charts of 370 patients, from the archive of Oral Diagnosis and Radiology Department of Marmara University Faculty of Dentistry (Istanbul, Turkey), with histologically confirmed clinical diagnosis of oral lichen planus in the period 1990-2010 were retrospectively reviewed…

AdultMalemedicine.medical_specialtyTurkish populationAdolescentTurkeyDentistryOdontologíaAsymptomaticYoung Adultstomatognathic systemmedicineHumansOral DiagnosisYoung adultskin and connective tissue diseasesGeneral DentistryAgedRetrospective StudiesAged 80 and overOral Medicine and Pathologyintegumentary systembusiness.industryRetrospective cohort studyMean ageMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseDermatologyCiencias de la saludstomatognathic diseasesOtorhinolaryngologyClinical diagnosisUNESCO::CIENCIAS MÉDICASSurgeryOral lichen planusFemaleResearch-Articlemedicine.symptombusinessLichen Planus OralMedicina oral, patologia oral y cirugia bucal
researchProduct

Vitiligo susceptibility and catalase gene (CAT) polymorphisms in sicilian population

2018

BACKGROUND Catalase gene (CAT) polymorphisms were analyzed as responsible for the deficiency of catalase enzyme activity and concomitant accumulation of excessive hydrogen peroxide in vitiligo patients. Catalase is a well-known oxidative stress regulator that could play an important role in the pathogenesis of vitiligo. This study was conducted to evaluate three CAT gene polymorphisms (-89A/T, 389C/T, 419C/T) and their association with vitiligo susceptibility in Sicilian population. METHODS Sixty out of 73 Sicilian patients with vitiligo were enrolled and submitted to CAT gene analysis. RESULTS Contrary to the Northern part of Europe but likewise to the Mediterranean area, the frequency of …

AdultMalevitiligoAdolescentGenotypePopulationDermatologyVitiligomedicine.disease_causePolymorphism Single NucleotidePathogenesis030207 dermatology & venereal diseases03 medical and health sciencesYoung Adult0302 clinical medicineCatalase GeneGenotypemedicineHumansGenetic Predisposition to Diseaseskin and connective tissue diseaseseducationSicily030203 arthritis & rheumatologyeducation.field_of_studyoxidative streintegumentary systembiologycatalaseHydrogen Peroxidemedicine.diseaseEnzyme assayCatalaseCase-Control StudiesImmunologybiology.proteinFemaleOxidative stress
researchProduct

Halloysite/Keratin Nanocomposite for Human Hair Photoprotection Coating

2020

We propose a novel keratin treatment of human hair by its aqueous mixtures with natural halloysite clay nanotubes. The loaded clay nanotubes together with free keratin produce micrometer-thick protective coating on hair. First, colloidal and structural properties of halloysite/keratin dispersions and the nanotube loaded with this protein were investigated. Above the keratin isoelectric point (pH = 4), the protein adsorption into the positive halloysite lumen is favored because of the electrostatic attractions. The ζ-potential magnitude of these core-shell particles increased from -35 (in pristine form) to -43 mV allowing for an enhanced colloidal stability (15 h at pH = 6). This keratin-cla…

AdultNanotubeMaterials scienceUltraviolet RaysRadiation-Protective Agentshalloysite nanotubes02 engineering and technologyengineering.material010402 general chemistry01 natural sciencesHalloysiteNanocompositesColloidCoatingKeratinHumansGeneral Materials SciencecompositekeratinSettore CHIM/02 - Chimica Fisicachemistry.chemical_classificationNanotubesNanocompositeintegumentary system021001 nanoscience & nanotechnologyhair treatment0104 chemical sciencesIsoelectric pointchemistryChemical engineeringUV-protective coatingengineeringClayKeratinsFemale0210 nano-technologyResearch ArticleHairProtein adsorptionACS Applied Materials & Interfaces
researchProduct

Induction of bone morphogenetic protein-6 in skin wounds. Delayed reepitheliazation and scar formation in BMP-6 overexpressing transgenic mice.

1998

Growth factors of the transforming growth factor-beta superfamily are involved in cutaneous wound healing. In this study we analyze the expression of the bone morphogenetic protein-6 (BMP-6) gene, a transforming growth factor-beta related gene, in skin wounds. In normal mouse skin high levels of BMP-6 mRNA and protein are expressed by postmitotic keratinocytes of stratified epidermis until day 6 after birth. BMP-6 expression is strongly reduced in adult epidermis with diminished mitotic activity. After skin injury we found large induction of BMP-6-specific RNA and protein in keratinocytes at the wound edge and keratinocytes of the newly formed epithelium as well as in fibroblast shaped cell…

AdultPathologymedicine.medical_specialtyBone Morphogenetic Protein 6Gene ExpressionMice TransgenicDermatologyBiologyBiochemistryMiceTransforming Growth Factor betaGene expressionmedicineAnimalsHumansFibroblastMolecular BiologySkinMessenger RNAWound Healingintegumentary systemEpidermis (botany)RNACell DifferentiationCell BiologyCell biologyUp-RegulationBone morphogenetic protein 6medicine.anatomical_structureBone Morphogenetic ProteinsRNAWounds and InjuriesWound healingCell DivisionTransforming growth factorThe Journal of investigative dermatology
researchProduct

Clinical and immunohistochemical evaluation of the vulvar Langerhans cell histiocytosis.

2008

:  We present the case of a woman with diabetes insipidus with subsequent genital and multiorgan Langerhans cell histiocytosis (LCH). A monolateral and slightly infiltrated erythematous plaque of the vulva was observed. Hematoxylin and eosin and immunophenotypic studies were performed. The primary antibodies used were monoclonal antibody to S100, CD1a, CD34, HLA-DR, PCNA, CD45Ro, CD40, and langerin. The histology of the infiltrates revealed a granulomatous reaction pattern, with extensive aggregates of histiocyte proliferation. The histiocytes, morphologically characterized by a pale staining of cytoplasm surrounding a grooved reniform nucleus, sometimes contained small distinct nucleoli. L…

AdultPathologymedicine.medical_specialtyCell typeLangerhans cellLangerinDermatologyVinblastineMethylprednisoloneImmunophenotypingVulvaLangerhans cell histiocytosisErythematous plaqueSettore MED/35 - Malattie Cutanee E VenereemedicineHumansHistiocyteCD40integumentary systembiologyHistiocytesGeneral Medicinemedicine.diseaseImmunohistochemistryHistiocytosis Langerhans-Cellmedicine.anatomical_structureTreatment Outcomevulvar Langerhans cell histiocytosisGiant cellErythemaLangerhans Cellsbiology.proteinDrug Therapy CombinationFemaleDiabetes InsipidusDermatologic therapy
researchProduct

VEGF-D expression correlates with colorectal cancer aggressiveness and is downregulated by cetuximab

2008

AIM: To gain mechanistic insights into the role played by epidermal growth factor receptor (EGFR) in the regulation of vascular endothelial growth factors (VEGFs) in colorectal cancer (CRC). METHODS: The impact of high-level expression of the growth factor receptors EGFR and VEGF receptor (VEGFR)3 and the VEGFR3 ligands VEGF-C and VEGF-D on disease progression and prognosis in human CRC was investigated in 108 patients using immunohistochemistry. Furthermore, the expression of the lymphangiogenic factors in response to the modulation of EGFR signalling by the EGFR-targeted monoclonal antibody cetuximab was investigated at the mRNA and protein level in human SW480 and SW620 CRC cell lines an…

AdultPathologymedicine.medical_specialtyColorectal cancerTransplantation HeterologousVascular Endothelial Growth Factor CVascular Endothelial Growth Factor DCetuximabAntineoplastic AgentsMice SCIDAntibodies Monoclonal HumanizedMiceGrowth factor receptorMice Inbred NODCell Line TumorMedicineAnimalsHumansEpidermal growth factor receptorneoplasmsAgedColorectal CancerAged 80 and overCetuximabbiologyintegumentary systembusiness.industryGastroenterologyVascular Endothelial Growth Factor DAntibodies MonoclonalGeneral MedicineMiddle Agedmedicine.diseaseVascular Endothelial Growth Factor Receptor-3digestive system diseasesLymphangiogenesisErbB ReceptorsVascular endothelial growth factor CCancer researchbiology.proteinImmunohistochemistryFemalebusinessColorectal NeoplasmsNeoplasm Transplantationmedicine.drugSignal Transduction
researchProduct

Immunohistochemical localization of filaggrin in benign, premalignant and malignant cervical tissue.

1994

Epithelial distribution of filaggrin, a histidine-rich protein related to squamous terminal differentiation, was investigated in 87 cervical biopsies using an avidin-biotin-peroxidase technique with a monoclonal anti-human filaggrin antibody (AKH1). Normal squamous cervical epithelium exhibited a positive homogeneous immunoperoxidase stain in the upper parabasal, intermediate and superficial cell layers. Similar findings were obtained in cervical condylomas, although full-thickness staining was observed in 35.7% of the cases (P < 0.001). Filaggrin expression in CIN was inversely related to the severity of the lesion (P < 0.001). An irregular staining pattern was present in most high-grade C…

AdultPathologymedicine.medical_specialtySquamous DifferentiationUterine Cervical NeoplasmsCervix UteriFilaggrin ProteinsLesionImmunoenzyme TechniquesUterine Cervical DiseasesIntermediate Filament ProteinsPredictive Value of TestsmedicineBiomarkers TumorHumansskin and connective tissue diseasesCervixintegumentary systemImmunoperoxidasebusiness.industryObstetrics and GynecologyGeneral MedicineUterine Cervical DysplasiaEpitheliumStainingmedicine.anatomical_structureCondylomata AcuminataCarcinoma Squamous CellImmunohistochemistryFemalemedicine.symptomEpidermisbusinessPrecancerous ConditionsCarcinoma in SituFilaggrin
researchProduct

Cytokeratin 20 Is a General Marker of Cutaneous Merkel Cells While Certain Neuronal Proteins Are Absent

1995

Merkel cells are difficult to identify in tissue sections. Previous studies have used cytokeratins (CK) 8, 18, and 19 as histologic markers of Merkel cells. However, these CKs are also expressed in some outer root sheath keratinocytes and some early fetal epidermal cells and thus are not truly specific of Merkel cells in general. Using selective antibodies against a newly described CK, number 20--originally found in intestinal epithelium and Merkel cell carcinomas--in comparison to a key protein of neuroendocrine cells, chromogranin A, we established CK 20 as a specific Merkel cell marker in skin of humans, pigs, and mice. CK 20 seems to be an even more general and sensitive Merkel cell mar…

AdultPathologymedicine.medical_specialtySwineCellHuman skinNerve Tissue ProteinsDermatologyKeratin-20BiologyOuter root sheathBiochemistryCytokeratinMiceFetusIntermediate Filament ProteinsmedicineAnimalsHumansMolecular BiologySkinintegumentary systemChromogranin APeripherinEpithelial CellsCell BiologyMolecular biologyImmunohistochemistrymedicine.anatomical_structurebiology.proteinMerkel cellNeuronal Cell Adhesion MoleculeBiomarkersHairJournal of Investigative Dermatology
researchProduct

Reconstructive surgery following resection of primary vulvar cancers.

2005

Objective. This study describes the surgical treatment and follow-up of 213 patients with primary vulvar cancer; particular attention is given to reconstructive surgical procedures. Methods. The clinical and pathological parameters of the patients were recorded according to standardized procedures, and the data concerning type of operation, surgical reconstruction and postoperative course of disease (recurrence-free and overall survival) were analyzed. Results. In about one-third of the cases, plastic surgery reconstruction involving skin-flaps was performed. In the present group of patients, plastic surgery procedures led to an elevated degree of operability as well as to more satisfactory…

AdultReconstructive surgerymedicine.medical_specialtySurgical FlapsResectionVulvamedicineHumansSurgical FlapsPathologicalAgedVulvar neoplasmAged 80 and overintegumentary systemVulvar Neoplasmsbusiness.industryObstetrics and GynecologyVulvar cancerMiddle AgedPlastic Surgery Proceduresmedicine.diseaseSurgeryPlastic surgerymedicine.anatomical_structureOncologyFemalebusinessFollow-Up StudiesGynecologic oncology
researchProduct

Rituximab in refractory pemphigus vulgaris

2008

Pemphigus vulgaris (PV) is a severe chronic autoimmune blistering disease of skin and mucous membranes. The use of systemic corticosteroids in pemphigus has dramatically reduced its mortality rate, but the long-term use of steroids leads to severe side effects, many of which are serious. For this reason it is often necessary to add immunosuppressive agents to the regimen. However, there are occasional refractory cases in which therapy with conventionally accepted modalities is either not efficacious or not possible on account of side effects. Rituximab is a therapeutic monoclonal antibody targeting CD20, an integral membrane protein highly expressed on the surface of pre-B lymphocytes and a…

Adultmedicine.medical_specialtyAntigens CD19B-Lymphocyte SubsetsDrug ResistanceDermatologyDrug Administration ScheduleAntibodies Monoclonal Murine-DerivedPharmacotherapyRefractoryRituximab pemphigus vulgarisimmune system diseasesHumansImmunologic FactorsMedicineInfusions IntravenousCD20integumentary systembiologybusiness.industryRemission InductionPemphigus vulgarisAntibodies MonoclonalGeneral MedicineAntigens CD20medicine.diseaseDermatologyRegimenPemphigusMonoclonalImmunologybiology.proteinPrednisoneDrug Therapy CombinationFemaleRituximabRituximabbusinessImmunosuppressive AgentsPemphigusmedicine.drugDermatologic Therapy
researchProduct